Alerts will be sent to your verified email
Verify Email
SANDUPHQ
|
Sandu Pharmaceutical
|
Medistep Healthcare
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.72 % | 24.77 % | 3.78 % |
|
5yr average Equity Multiplier
|
1.33 | 1.32 | 3.3 |
|
5yr Average Asset Turnover Ratio
|
1.23 | 2.13 | 0.77 |
|
5yr Avg Net Profit Margin
|
2.27 % | 8.79 % | -2.26 % |
|
Price to Book
|
0.81 | 1.9 | 0.56 |
|
P/E
|
21.6 | 7.8 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
48.49 Days | 115.71 Days | 70.26 Days |
|
Inventory Days
|
74.6 Days | 9.08 Days | 107.37 Days |
|
Days Receivable
|
26.14 Days | 124.47 Days | 274.82 Days |
|
Days Payable
|
72.73 Days | 17.5 Days | 235.98 Days |
|
5yr Average Interest Coverage Ratio
|
28.2 | 96.98 | 1.81 |
|
5yr Avg ROCE
|
5.33 % | 33.38 % | 15.08 % |
|
5yr Avg Operating Profit Margin
|
3.77 % | 11.92 % | 7.68 % |
|
5 yr average Debt to Equity
|
0.0 | 0.04 | 0.97 |
|
5yr CAGR Net Profit
|
0.39 % | 35.1 % | n/a |
|
5yr Average Return on Assets
|
2.79 % | 18.77 % | 1.04 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
37.79 % | 68.96 % | 70.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 44.88 % |
|
Change in Promoter Holding (3 Yrs)
|
-12.64 % | 0.0 | -0.55 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sandu Pharmaceutical
|
Medistep Healthcare
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|